http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2798153-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6493e075b586cf5568b69116429349a8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T156-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate | 2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a2ea096191ba057731fa51566ce81c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784f6a43e08f731ce452a7570149ac85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307b64fa8c0fa144f992a08ea23c9c5b |
| publicationDate | 2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2798153-T3 |
| titleOfInvention | Transdermal therapeutic system with controlled active ingredient fluence, containing an oxide that reacts in a basic way |
| abstract | Transdermal therapeutic system, comprising an occlusive back layer, impermeable to the active principle, a matrix of one or more layers and a peelable protective sheet, characterized in that the matrix or at least one of the matrix layers contains a pharmaceutical active principle or several principles Pharmaceutical active ingredients in the form of at least one of its pharmaceutically acceptable salts and an oxide that reacts in a basic way in contact with water, pharmaceutically acceptable, this reaction not starting until after the application of the STT on the skin due to the absorption of water and the pharmaceutical active ingredient / pharmaceutical active ingredients and oxide / oxides being contained in different matrix layers. |
| priorityDate | 2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.